Mitochondria! Regulation of the 26S Proteasome

Meul, Thomas; Berschneider, Korbinian; Schmitt, Sabine; Mayr, Christoph H.; Mattner, Laura F.; Schiller, Herbert B.; Yazgili, Ayse S.; Wang, Xinyuan; Lukas, Christina; Schlesser, Camille; Prehn, Cornelia; Adamski, Jerzy; Graf, Elisabeth; Schwarzmayr, Thomas; Perocchi, Fabiana; Kukat, Alexandra; Trifunovic, Aleksandra; Kremer, Laura; Prokisch, Holger; Popper, Bastian; Toerne, Christine von; Hauck, Stefanie M.; Zischka, Hans und Meiners, Silke (2020): Mitochondria! Regulation of the 26S Proteasome. In: Cell Reports, Bd. 32, Nr. 8, 108059

Abstract

The proteasome is the main proteolytic system for targeted protein degradation in the cell and is fine-tuned according to cellular needs. Here, we demonstrate that mitochondrial dysfunction and concomitant metabolic reprogramming of the tricarboxylic acid (TCA) cycle reduce the assembly and activity of the 26S proteasome. Both mitochondrial mutations in respiratory complex I and treatment with the anti-diabetic drug metformin impair 26S proteasome activity. Defective 26S assembly is reversible and can be overcome by supplementation of aspartate or pyruvate. This metabolic regulation of 26S activity involves specific regulation of proteasome assembly factors via the mTORC1 pathway. Of note, reducing 26S activity by metformin confers increased resistance toward the proteasome inhibitor bortezomib, which is reversible upon pyruvate supplementation. Our study uncovers unexpected consequences of defective mitochondrial metabolism for proteasomal protein degradation in the cell, which has important pathophysiological and therapeutic implications.

• Dokumententyp: Zeitschriftenartikel
• Fakultät: Medizin > Munich Cluster for Systems Neurology (SyNergy)
• Themengebiete: 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit
• ISSN: 2211-1247
• Sprache: Englisch
• DFG: Gefördert durch die Deutsche Forschungsgemeinschaft (DFG) - 390857198